Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now LSE - Delayed Quote • GBp Scancell Holdings plc (SCLP.L) Follow Compare 10.50 +0.50 +(5.00%) At close: April 17 at 3:57:21 PM GMT+1 All News Press Releases SEC Filings With 42% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interest Key Insights Significantly high institutional ownership implies Scancell Holdings' stock price is sensitive to their... PharmaJet signs deal with Scancell for needle-free melanoma vaccine Scancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product. Hedge funds investors control 42% of Scancell Holdings plc (LON:SCLP) and were rewarded last week after stock increased 13% Key Insights Institutions' substantial holdings in Scancell Holdings implies that they have significant influence over... Performance Overview Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) Return SCLP.L FTSE 100 (^FTSE) YTD -2.33% +1.26% 1-Year +9.95% +5.45% 3-Year -38.21% +8.66%